Logo image of PD

PAGERDUTY INC (PD) Stock Fundamental Analysis

NYSE:PD - New York Stock Exchange, Inc. - US69553P1003 - Common Stock - Currency: USD

15.46  -0.13 (-0.83%)

After market: 15.78 +0.32 (+2.07%)

Fundamental Rating

3

Taking everything into account, PD scores 3 out of 10 in our fundamental rating. PD was compared to 282 industry peers in the Software industry. PD has a bad profitability rating. Also its financial health evaluation is rather negative. PD has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year PD was profitable.
PD had a positive operating cash flow in the past year.
In the past 5 years PD always reported negative net income.
Of the past 5 years PD 4 years had a positive operating cash flow.
PD Yearly Net Income VS EBIT VS OCF VS FCFPD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

With a Return On Assets value of -5.87%, PD perfoms like the industry average, outperforming 46.45% of the companies in the same industry.
The Return On Equity of PD (-41.95%) is worse than 65.25% of its industry peers.
Industry RankSector Rank
ROA -5.87%
ROE -41.95%
ROIC N/A
ROA(3y)-10.14%
ROA(5y)-10.48%
ROE(3y)-47.62%
ROE(5y)-40.38%
ROIC(3y)N/A
ROIC(5y)N/A
PD Yearly ROA, ROE, ROICPD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100

1.3 Margins

PD's Gross Margin of 82.96% is amongst the best of the industry. PD outperforms 91.13% of its industry peers.
PD's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for PD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y-0.54%
PD Yearly Profit, Operating, Gross MarginsPD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 80

3

2. Health

2.1 Basic Checks

PD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PD has been reduced compared to 1 year ago.
PD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PD has a worse debt to assets ratio.
PD Yearly Shares OutstandingPD Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
PD Yearly Total Debt VS Total AssetsPD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.92, we must say that PD is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.92, PD is not doing good in the industry: 61.35% of the companies in the same industry are doing better.
The Debt to FCF ratio of PD is 4.16, which is a neutral value as it means it would take PD, 4.16 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of PD (4.16) is better than 60.28% of its industry peers.
PD has a Debt/Equity ratio of 3.03. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 3.03, PD is not doing good in the industry: 82.27% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 3.03
Debt/FCF 4.16
Altman-Z 0.92
ROIC/WACCN/A
WACC9.6%
PD Yearly LT Debt VS Equity VS FCFPD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.93 indicates that PD should not have too much problems paying its short term obligations.
PD has a better Current ratio (1.93) than 60.28% of its industry peers.
PD has a Quick Ratio of 1.93. This is a normal value and indicates that PD is financially healthy and should not expect problems in meeting its short term obligations.
PD has a better Quick ratio (1.93) than 60.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.93
PD Yearly Current Assets VS Current LiabilitesPD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

5

3. Growth

3.1 Past

PD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.32%, which is quite impressive.
PD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.56%.
Measured over the past years, PD shows a very strong growth in Revenue. The Revenue has been growing by 22.95% on average per year.
EPS 1Y (TTM)24.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.18%
Revenue 1Y (TTM)8.56%
Revenue growth 3Y18.44%
Revenue growth 5Y22.95%
Sales Q2Q%7.77%

3.2 Future

PD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.80% yearly.
The Revenue is expected to grow by 6.60% on average over the next years.
EPS Next Y20.21%
EPS Next 2Y17.02%
EPS Next 3Y16.8%
EPS Next 5YN/A
Revenue Next Year6.68%
Revenue Next 2Y7.04%
Revenue Next 3Y6.6%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PD Yearly Revenue VS EstimatesPD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
PD Yearly EPS VS EstimatesPD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.80 indicates a correct valuation of PD.
Compared to the rest of the industry, the Price/Earnings ratio of PD indicates a rather cheap valuation: PD is cheaper than 81.91% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.48, PD is valued a bit cheaper.
PD is valuated correctly with a Price/Forward Earnings ratio of 13.28.
PD's Price/Forward Earnings ratio is rather cheap when compared to the industry. PD is cheaper than 87.94% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.04. PD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 16.8
Fwd PE 13.28
PD Price Earnings VS Forward Price EarningsPD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

PD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PD is cheaper than 90.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.14
EV/EBITDA N/A
PD Per share dataPD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

PD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PD's earnings are expected to grow with 16.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.83
PEG (5Y)N/A
EPS Next 2Y17.02%
EPS Next 3Y16.8%

0

5. Dividend

5.1 Amount

No dividends for PD!.
Industry RankSector Rank
Dividend Yield N/A

PAGERDUTY INC

NYSE:PD (8/8/2025, 8:04:00 PM)

After market: 15.78 +0.32 (+2.07%)

15.46

-0.13 (-0.83%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-29 2025-05-29/amc
Earnings (Next)08-28 2025-08-28/amc
Inst Owners93.33%
Inst Owner Change-2.01%
Ins Owners4.54%
Ins Owner Change8.58%
Market Cap1.42B
Analysts74
Price Target18.93 (22.45%)
Short Float %11.49%
Short Ratio5.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)39.15%
Min EPS beat(2)32.22%
Max EPS beat(2)46.08%
EPS beat(4)4
Avg EPS beat(4)32.75%
Min EPS beat(4)21.72%
Max EPS beat(4)46.08%
EPS beat(8)8
Avg EPS beat(8)49.23%
EPS beat(12)12
Avg EPS beat(12)78.04%
EPS beat(16)16
Avg EPS beat(16)64.18%
Revenue beat(2)0
Avg Revenue beat(2)-1.22%
Min Revenue beat(2)-1.55%
Max Revenue beat(2)-0.89%
Revenue beat(4)0
Avg Revenue beat(4)-2.24%
Min Revenue beat(4)-3.36%
Max Revenue beat(4)-0.89%
Revenue beat(8)1
Avg Revenue beat(8)-1.9%
Revenue beat(12)2
Avg Revenue beat(12)-1.47%
Revenue beat(16)3
Avg Revenue beat(16)-1.15%
PT rev (1m)0.3%
PT rev (3m)-8.47%
EPS NQ rev (1m)1.48%
EPS NQ rev (3m)1.48%
EPS NY rev (1m)0.8%
EPS NY rev (3m)6.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-1.33%
Valuation
Industry RankSector Rank
PE 16.8
Fwd PE 13.28
P/S 3.05
P/FCF 13.14
P/OCF 12.09
P/B 10.98
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.92
EY5.95%
EPS(NY)1.16
Fwd EY7.53%
FCF(TTM)1.18
FCFY7.61%
OCF(TTM)1.28
OCFY8.27%
SpS5.07
BVpS1.41
TBVpS-0.31
PEG (NY)0.83
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.87%
ROE -41.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.96%
FCFM 23.19%
ROA(3y)-10.14%
ROA(5y)-10.48%
ROE(3y)-47.62%
ROE(5y)-40.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y-0.54%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 3.03
Debt/FCF 4.16
Debt/EBITDA N/A
Cap/Depr 46%
Cap/Sales 2.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.93
Quick Ratio 1.93
Altman-Z 0.92
F-Score7
WACC9.6%
ROIC/WACCN/A
Cap/Depr(3y)47.55%
Cap/Depr(5y)63.23%
Cap/Sales(3y)2.19%
Cap/Sales(5y)2.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.18%
EPS Next Y20.21%
EPS Next 2Y17.02%
EPS Next 3Y16.8%
EPS Next 5YN/A
Revenue 1Y (TTM)8.56%
Revenue growth 3Y18.44%
Revenue growth 5Y22.95%
Sales Q2Q%7.77%
Revenue Next Year6.68%
Revenue Next 2Y7.04%
Revenue Next 3Y6.6%
Revenue Next 5YN/A
EBIT growth 1Y32.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.96%
EBIT Next 3Y24.41%
EBIT Next 5YN/A
FCF growth 1Y68.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.8%
OCF growth 3YN/A
OCF growth 5YN/A